Patents by Inventor Deborah A. Buonagurio

Deborah A. Buonagurio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEQUENCE ANALYSIS OF THE TETRAVALENT ROTAVIRUS VACCINE
    Publication number: 20090246829
    Abstract: Isolated nucleic acid molecules comprising a gene segment from a rhesus rotavirus (RRV) or from one of three rhesus:human reassortant viruses are disclosed, including isolated nucleic acid molecules having a sequence selected from the group consisting of: SEQ ID NO: 1-14, inclusive, and isolated nucleic acid molecules encoding a protein having a sequence selected from the group consisting of SEQ ID NO: 15-28, inclusive, as well as variants of the isolated nucleic acid molecules.
    Type: Application
    Filed: February 3, 2009
    Publication date: October 1, 2009
    Applicants: Services
    Inventors: Deborah A. Buonagurio, Alice F. Georgiu, Robert A. Lerch, Bruce B. Mason, Shridhara C. Murthy, Ruth S. Rappaport, Mohinder S. Sidhu, Stephen A. Udem, Timothy J. Zamb
  • Sequence analysis of the tetravalent rotavirus vaccine
    Patent number: 7485415
    Abstract: Isolated nucleic acid molecules comprising a gene segment from a rhesus rotavirus (RRV) or from one of three rhesus: human reassortant viruses are disclosed, including isolated nucleic acid molecules having a sequence selected from the group consisting of: SEQ ID NO: 1-14, inclusive, and isolated nucleic acid molecules encoding a protein having a sequence selected from the group consisting of SEQ ID NO: 15-28, inclusive, as well as variants of the isolated nucleic acid molecules.
    Type: Grant
    Filed: February 19, 2003
    Date of Patent: February 3, 2009
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Deborah A. Buonagurio, Alice F. Georgiu, Robert A. Lerch, Bruce B. Mason, Shridhara C. Murthy, Ruth S. Rappaport, Mohinder S. Sidhu, Stephen A. Udem, Timothy J. Zamb
  • Sequence analysis of the tetravalent rotavirus vaccine
    Publication number: 20050119471
    Abstract: Isolated nucleic acid molecules comprising a gene segment from a rhesus rotavirus (RRV) or from one of three rhesus: human reassortant viruses are disclosed, including isolated nucleic acid molecules having a sequence selected from the group consisting of: SEQ ID NO: 1-14, inclusive, and isolated nucleic acid molecules encoding a protein having a sequence selected from the group consisting of SEQ ID NO: 15-28, inclusive, as well as variants of the isolated nucleic acid molecules.
    Type: Application
    Filed: February 19, 2003
    Publication date: June 2, 2005
    Applicant: THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Deborah Buonagurio, Alice Georgiu, Robert Lerch, Bruce Mason, Shridhara Murthy, Ruth Rappaport, Mohinder Sidhu, Stephen Udem, Timothy Zamb
  • Construction and expression of synthetic genes encoding envelope epitopes of the human T cell leukemia virus type I
    Patent number: 5837818
    Abstract: A synthetic gene which codes for at least one epitope from the immunodominant conserved region of HTLV-I env. gp 21 as well as hybrid genes utilizing the synthetic gene in conjunction with other epitopes from HTLV-Ienv.
    Type: Grant
    Filed: August 2, 1996
    Date of Patent: November 17, 1998
    Assignee: Roche Diagnostic Systems, Inc.
    Inventors: Deborah A. Buonagurio, Mathew Longiaru